The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Ciprofloxacin or Tamsulosin in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized, Double-Blind Trial
Abstract
BACKGROUND: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men is principally defined by pain in the pelvic region lasting more than 3 months. No cause of the disease has been established, and therapies are empirical and mostly untested. Antimicrobial agents and alpha-adrenergic receptor blockers are frequently used. OBJECTIVE: To determine whether 6-week therapy with ciprofloxacin or tamsulosin is more effective than placebo at improving symptoms in men with refractory, long-standing CP/CPPS. DESIGN: Randomized, double-blind trial with a 2 x 2 factorial design comparing 6 weeks of therapy with ciprofloxacin, tamsulosin, both drugs, or placebo. SETTING: Urology outpatient clinics at 10 tertiary care medical centers in North America. PATIENTS: Patients were identified from referral-based practices of urologists. One hundred ninety-six men with a National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) score of at least 15 and a mean of 6.2 years of symptoms were enrolled. Patients had received substantial previous treatment. MEASUREMENTS: The authors evaluated NIH-CPSI total score and subscores, patient-reported global response assessment, a generic measure of quality of life, and adverse events. INTERVENTIONS: Ciprofloxacin, 500 mg twice daily; tamsulosin, 0.4 mg once daily; a combination of the 2 drugs; or placebo. RESULTS: The NIH-CPSI total score decreased modestly in all treatment groups. No statistically significant difference in the primary outcome was seen for ciprofloxacin versus no ciprofloxacin (P = 0.15) or tamsulosin versus no tamsulosin (P > 0.2). Treatments also did not differ significantly for any of the secondary outcomes. LIMITATIONS: Treatment lasting longer than 6 weeks was not tested. Patients who had received less pretreatment may have responded differently. CONCLUSION: Ciprofloxacin and tamsulosin did not substantially reduce symptoms in men with long-standing CP/CPPS who had at least moderate symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, two of the larger, placebo‐controlled trials that evaluated tamsulosin (n = 196) 53 and alfuzosin (n = 272) 57 failed to show any significant difference in total NIH‐CPSI scores, the only outcome achieving statistical significance being the score for ejaculation on the Male Sexual Health Questionnaire (P = 0.04) in the alfuzosin trial.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [53]
In the citing paper
“Although symptom improvement was observed, the ciprofloxacin study failed to show a statistical difference in NIH‐CPSI total score from baseline to 6 weeks in a CP/CPPS population 53.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [53]
In the citing paper
“Only three small‐to‐medium sized (n = 48–196), adequately designed RCTs, which assessed ciprofloxacin 53, levofloxacin 48, and tetracycline hydrochloride 72 vs placebo in patients with CP/CPPS, were identified.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [53]
In the citing paper
“In a placebo‐controlled trial, which compared tamsulosin vs ciprofloxacin vs a combination of both over 6 weeks in CP/CPPS, the total NIH‐CPSI scores demonstrated significant mean improvement of 3–6 points from baseline in all treatment groups. However, no statistically significant differences between treatment groups were seen 53.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [53]
In the citing paper
“In all, 10 placebo‐controlled RCTs (n = 58–272) were identified that evaluated α‐adrenergic antagonists (tamsulosin 53, 54, 55, alfuzosin 56, 57, doxazosin 58, 59, terazosin 60, 61 and silodosin 62) in CBP and CP/CPPS.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
(2001) · Statistics for Psychologists · doi:10.4324/9781410605542-11 · Cited by 6,877
NIH Consensus Definition and Classification of Prostatitis
Krieger, J. N., Nyberg, Jr., & Nickel, J. C. (1999) · JAMA · doi:10.1001/jama.282.3.236 · Cited by 1,473
Self-citationLITWIN, M. S., McNAUGHTON-COLLINS, M., FOWLER, F. J., NICKEL, J. C., CALHOUN, E. A., PONTARI, M. A., ALEXANDER, R. B., FARRAR, J. T., & O'LEARY, M. P. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68562-x · Cited by 947
Self-citationHOW COMMON IS PROSTATITIS? A NATIONAL SURVEY OF PHYSICIAN VISITS
COLLINS, M. M., STAFFORD, R. S., O'LEARY, M. P., & BARRY, M. J. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63564-x · Cited by 658
Self-citationNickel, J. C., Downey, J., Hunter, D., & Clark, J. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)66541-x · Cited by 457
Self-citationRoberts, R. O., Lieber, M. M., Rhodes, T., Girman, C. J., Bostwick, D. G., & Jacobsen, S. J. (1998) · Urology · doi:10.1016/s0090-4295(98)00034-x · Cited by 294
the Chronic Prostatitis Collaborative Research Network, McNaughton Collins, M., Pontari, M. A., O’Leary, M. P., Calhoun, E. A., Santanna, J., Landis, J. R., Kusek, J. W., & Litwin, M. S. (2001) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2001.01223.x · Cited by 281
Self-citationSchaeffer, A. J., Knauss, J. S., Landis, J. R., Propert, K. J., Alexander, R. B., Litwin, M. S., Nickel, J. C., O’leary, M. P., Nadler, R. B., Pontari, M. A., et al. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64572-7 · Cited by 237
Self-citationSchaeffer, A. J., Landis, J. R., Knauss, J. S., Propert, K. J., Alexander, R. B., Litwin, M. S., Nickel, J. C., O'leary, M. P., Nadler, R. B., Pontari, M. A., et al. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64686-1 · Cited by 223
Self-citation
Cited by
EAU Guidelines on Chronic Pelvic Pain
Fall, M., Baranowski, A. P., Elneil, S., Engeler, D., Hughes, J., Messelink, E. J., Oberpenning, F., & de C. Williams, A. C. (2010) · European Urology · doi:10.1016/j.eururo.2009.08.020 · Cited by 579
Rees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG) (2015) · BJU International · doi:10.1111/bju.13101 · Cited by 371
Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Magistro, G., Wagenlehner, F. M. E., Grabe, M., Weidner, W., Stief, C. G., & Nickel, J. C. (2016) · European Urology · doi:10.1016/j.eururo.2015.08.061 · Cited by 294
Self-citationAnothaisintawee, T. (2011) · JAMA · doi:10.1001/jama.2010.1913 · Cited by 278
The MAPP research network: a novel study of urologic chronic pelvic pain syndromes
The MAPP Research Network Study Group, Clemens, J. Q., Mullins, C., Kusek, J. W., Kirkali, Z., Mayer, E. A., Rodríguez, L. V., Klumpp, D. J., Schaeffer, A. J., Kreder, K. J., et al. (2014) · BMC Urology · doi:10.1186/1471-2490-14-57 · Cited by 155
Self-citation
Metadata
- Authors
- Alexander, R. B., Propert, K. J., Schaeffer, A. J., Landis, J. R., Nickel, J. C., O'Leary, M. P., Pontari, M. A., McNaughton-Collins, M., Shoskes, D. A., Comiter, C. V., Datta, N. S., Fowler, J. E., Nadler, R. B., Zeitlin, S. I., Knauss, J. S., Wang, Y., Kusek, J. W., Nyberg, L. M., Litwin, M. S., & and the Chronic Prostatitis Collaborative Research Network*
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2004-10-19
- Volume
- 141
- Issue
- 8
- Pages
- 581-589
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2149820490
- Cited by
- 262
- References
- 21
- FWCI
- 22.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ciprofloxacin or Tamsulosin in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized, Double-Blind Trial. https://app.cochat.ai/papers/10.7326/0003-4819-141-8-200410190-00005
- The paper
- Alexander, R. B., Propert, K. J., Schaeffer, A. J., Landis, J. R., Nickel, J. C., O'Leary, M. P., Pontari, M. A., McNaughton-Collins, M., Shoskes, D. A., Comiter, C. V., Datta, N. S., Fowler, J. E., Nadler, R. B., Zeitlin, S. I., Knauss, J. S., Wang, Y., Kusek, J. W., Nyberg, L. M., Litwin, M. S., & and the Chronic Prostatitis Collaborative Research Network*. (2004). Ciprofloxacin or Tamsulosin in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized, Double-Blind Trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-141-8-200410190-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.